SS-31 vs MOTS-C: Two Mitochondrial-Targeted Peptides in Research

For Research Use Only. Not for human or veterinary use. All information below is intended for qualified research professionals at accredited institutions.

TL;DR

SS-31 (Elamipretide) is a synthetic cardiolipin-binding tetrapeptide that localizes to the inner mitochondrial membrane, studied in electron transport chain and bioenergetics research.
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded by mitochondrial DNA, studied as a retrograde mitochondria-to-nucleus signaling molecule in metabolic and exercise physiology contexts.
The two peptides are mechanistically distinct: SS-31 acts at the mitochondrial membrane level on biophysical parameters; MOTS-C acts as a gene-regulatory signaling peptide across cellular compartments.

Mitochondria have emerged as a rich source of research tool compounds. Beyond their canonical role as ATP-producing organelles, mitochondria participate in cell signaling, ROS homeostasis, calcium buffering, and apoptosis regulation. Two research peptides — SS-31 and MOTS-C — represent distinct approaches to studying mitochondrial biology: one engineered to target the organelle’s inner membrane directly, the other naturally encoded within mitochondrial DNA and studied as an inter-compartmental signaling entity. This overview compares their mechanisms, research contexts, and specifications for research professionals selecting between these tool compounds.

Mechanism: SS-31 (Elamipretide)

SS-31, also known as Elamipretide or MTP-131, is a synthetic aromatic-cationic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH₂, where Dmt represents the non-natural amino acid 2′,6′-dimethyltyrosine. This alternating pattern of aromatic and cationic residues is integral to its mechanism of action.

Cardiolipin binding: The primary documented mechanism of SS-31 involves high-affinity interaction with cardiolipin (CL), an anionic phospholipid found almost exclusively in the inner mitochondrial membrane (IMM). Cardiolipin is essential for the structural organization of the IMM, serving as a scaffold for the respiratory chain supercomplexes (Complexes I, III, and IV assembled into respirasomes). Cardiolipin peroxidation — which occurs under conditions of elevated mitochondrial ROS — disrupts supercomplex organization and impairs electron transport chain (ETC) efficiency. SS-31’s binding to cardiolipin has been characterized in published research as stabilizing the cardiolipin structure and reducing cardiolipin peroxidation in oxidative stress model systems.

ETC and bioenergetics effects: Research studies examining SS-31 in isolated mitochondria, cell culture, and animal models have documented effects on ETC complex activity, mitochondrial membrane potential (ΔΨm), ATP production rates, and oxygen consumption rates (OCR) measured by respirometry. The proposed mechanism links cardiolipin stabilization to improved supercomplex assembly and reduced electron leak to oxygen (and thus ROS generation). Studies in cardiomyocyte models, kidney proximal tubule cells, and skeletal muscle preparations have used SS-31 as a tool to probe the relationship between cardiolipin integrity and bioenergetic capacity.

Mitochondrial targeting mechanism: SS-31 accumulates at the IMM through electrostatic interactions driven by the large negative membrane potential across the IMM (approximately -180 mV). The cationic residues (D-Arg, Lys) drive electrostatic accumulation without requiring a targeting sequence, distinguishing it from fusion proteins or MitoQ-type triphenylphosphonium-conjugated antioxidants.

Key specifications:

Sequence: D-Arg-Dmt-Lys-Phe-NH₂ (tetrapeptide)
Molecular formula: C₃₂H₄₉N₉O₅
MW: 639.80 Da
Purity: ≥99% HPLC
Available: 10mg × 10 vials
Storage: -20°C, desiccated
Product page: glunovabiotech.com/products/ss-31

Mechanism: MOTS-C

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide with the sequence MRWQEMGYIFYPRKLR, encoded within a short open reading frame (sORF) in the mitochondrial 12S rRNA gene. It was discovered and characterized as part of systematic screening for small mitochondrial-encoded peptides, now termed mitochondria-derived peptides (MDPs).

Mitochondrial genomic origin: The mitochondrial genome is a compact, 16,569 bp circular DNA molecule encoding 13 proteins (all ETC subunits or ATP synthase components), 22 tRNAs, and 2 rRNAs. MOTS-C’s discovery within the 12S rRNA gene region challenged the assumption that this locus encoded only structural RNA, demonstrating that mitochondrial-encoded sORFs can produce bioactive peptides. This places MOTS-C in the emerging class of mitochondria-derived retrograde signaling molecules.

Nuclear translocation and gene regulation: Unlike SS-31, which acts locally at the IMM, published research has documented MOTS-C’s translocation from mitochondria to the nucleus under metabolic stress conditions. In the nucleus, MOTS-C has been reported to interact with promoter regions of genes involved in metabolic adaptation, including those in the folate-methionine cycle, AMPK pathway targets, and antioxidant response element (ARE)-driven genes. This mitochondria-to-nucleus communication represents a form of retrograde signaling distinct from classical mitochondrial stress signals like ROS or calcium flux.

Metabolic and exercise physiology research: MOTS-C has been studied in the context of glucose uptake in skeletal muscle cells (via GLUT4 translocation and AMPK activation), insulin sensitivity models, and exercise-related metabolic adaptations. Research in rodent models has examined MOTS-C administration effects on physical performance parameters and metabolic gene expression. Its circulating levels have been measured in human studies correlating with age and metabolic parameters, though Glunova Biotech’s MOTS-C is supplied exclusively for laboratory research use.

Key specifications:

Sequence: MRWQEMGYIFYPRKLR (16 AA)
CAS: 1627580-64-6
MW: ~2,174 Da
Purity: ≥99% HPLC
Available: 20mg × 10 vials
Storage: -20°C, desiccated
Product page: glunovabiotech.com/products/mots-c

Comparison Table

Parameter	SS-31 (Elamipretide)	MOTS-C
Origin	Synthetic (engineered aromatic-cationic peptide)	Endogenous (mitochondrial DNA-encoded)
Sequence length	4 amino acids (tetrapeptide)	16 amino acids
MW	639.80 Da	~2,174 Da
CAS	Not assigned (synthetic construct)	1627580-64-6
Primary target	Cardiolipin (inner mitochondrial membrane)	Nucleus (via mitochondria-to-nucleus translocation)
Primary mechanism	Cardiolipin binding, ETC supercomplex stabilization	Retrograde mitochondria-nucleus signaling, gene regulation
Key research pathways	ETC, ROS, ΔΨm, bioenergetics	AMPK, folate-methionine cycle, ARE-driven genes
Research context	Bioenergetics, oxidative stress, cardiac/skeletal muscle	Metabolic adaptation, exercise physiology, aging
Available packaging	10mg × 10 vials	20mg × 10 vials
Purity	≥99% HPLC	≥99% HPLC

Research Applications

SS-31 research applications:

Cardiolipin peroxidation assays and IMM integrity studies
ETC complex I–IV activity measurements in isolated mitochondria (Seahorse XF or Clark electrode-based respirometry)
Mitochondrial membrane potential (ΔΨm) assays using JC-1 or TMRE fluorescent probes
Oxidative stress models in cardiomyocytes, renal tubular cells, or neuronal cell lines
Aging-related mitochondrial dysfunction models where cardiolipin remodeling is studied
ROS production studies using MitoSOX or similar mitochondria-targeted fluorescent probes

MOTS-C research applications:

AMPK activation assays in skeletal muscle cell lines (C2C12 myotubes)
GLUT4 translocation studies in insulin sensitivity models
Mitochondrial retrograde signaling pathway research (mitochondria-to-nucleus communication)
Folate-methionine cycle and one-carbon metabolism research
Gene expression profiling after MOTS-C treatment (ARE-driven antioxidant gene panels)
Aging and longevity model research where mitochondrial-derived peptide signaling is studied

Selecting Between SS-31 and MOTS-C

The choice between these two peptides depends entirely on the research question:

Select SS-31 for bioenergetics-focused experiments where the research question concerns membrane-level mitochondrial function: ETC activity, cardiolipin integrity, ATP production, or mitochondrial ROS in models of oxidative stress or mitochondrial dysfunction.
Select MOTS-C for research into mitochondrial signaling beyond the organelle — particularly inter-compartmental communication, AMPK pathway modulation, or metabolic gene regulation studies where the mitochondria-to-nucleus axis is the subject of investigation.
Use both in parallel when studying the multi-layered mitochondrial stress response, where both biophysical (cardiolipin/ETC) and transcriptional (retrograde signaling) dimensions are being characterized simultaneously.

Ordering Information

Both SS-31 and MOTS-C are available from Glunova Biotech LLC at ≥99% HPLC purity with full COA per lot:

For bulk research orders, institutional pricing, COA documentation, SDS, or supply agreements, contact dylan.tom2012@gmail.com or call +1 (586) 248-1681.

For Research Use Only. Not for human or veterinary use. These products have not been evaluated by the FDA or any regulatory agency for safety or efficacy in humans or animals.